An independent maker, unaffiliated with the official Spectrum Next Kickstarter team, has built a redesigned laptop housing for the ZX Spectrum Next dev board. The new version uses salvaged laptop hinges, a 14-inch HD screen supporting both HDMI and VGA, and an authentic Spectrum Next keyboard in place of the generic USB keyboard used in the first attempt. It also adds a touchpad, dual micro-SD slots, stereo speakers with volume control, dual joystick ports, and USB connectivity.
dorchester3d.com
· 2026-10-19
A hobbyist programmer has finished a retro-style demoscene intro running on a stock 128Kb ZX Spectrum, featuring a scrolling text with custom fonts, a three-channel AY soundtrack, VU meters and a parallax starfield. The project, started on December 13th, compiles to 10287 bytes of code (19552 bytes as a full tape image), and is available as a downloadable .tap file, a YouTube capture, a pouet.net listing, and a browser-runnable version via the creator's TNFS site.
markround.com
· 2026-10-12
The GamerCard handheld device suffers from inconsistent controls, lacking a dedicated Home button and physical volume controls, which complicates navigation and system management. Its Bluetooth connectivity is unreliable, and loading ROMs for emulation is hindered by the absence of an easy microSD card ejection method. Despite its potential for emulation, these hardware shortcomings limit its practical use.
wired.com
· 2026-10-06
Braden Sinclair, one of only 50 people ever awarded Olive Garden's Lifetime Pasta Pass, has launched a website called Lifetimepastapass.com that tracks his meals and lets visitors vote on what he should order next. He won the unlimited-dining privilege in 2019 through a rare Olive Garden promotion, distinct from the chain's more common 13-week Never Ending Pasta Pass offers.
wired.com
· 2026-09-11
Geneticist Yuancheng Lu, working in David Sinclair's Harvard lab, developed a reprogramming gene therapy in 2018 that regenerated crushed optic nerves in mice and restored their vision. That same therapy, now called ER-100, has been adapted for humans by the startup Life Biosciences, which in June injected it into the eye of a glaucoma patient as part of a clinical trial.
technologyreview.com
· 2026-09-08